JENNIFER TAPIA: Open Payments
NPI 1285224097 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,475 in 78 payments from 14 companies in 2025. Trend: 2023 $226 · 2024 $838 · 2025 $2,475
Food & beverage: $1,451Travel & lodging: $1,024
| Company | Payments | Amount |
|---|---|---|
| INTUITIVE SURGICAL, INC. | 3 | $1,024 |
| Neurocrine BioSciences, Inc. | 14 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $218 |
| Alkermes, Inc. | 10 | $197 |
| ABBVIE INC. | 11 | $162 |
| Otsuka America Pharmaceutical, Inc. | 8 | $155 |
| Supernus Pharmaceuticals, Inc. | 6 | $123 |
| E.R. Squibb & Sons, L.L.C. | 5 | $91 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
Products named: Da Vinci Surgical System, INGREZZA, CAPLYTA, ARISTADA, VRAYLAR, REXULTI, Qelbree, COBENFY.
Industry payments across CA — which companies pay providers there.
